Apricity has raised €6m in its Series A funding round from AXA’s Kamet Ventures.
The world’s first virtual fertility clinic’s total has now reached €8.8m.
Apricity combines medical excellence with human care and new technologies by applying AI to increase chances of conception.
Caroline Noublanche, CEO and Co-Founder of Apricity, said: “We are thrilled that for such a new company, we have seen such amazing support from AXA and Kamet Ventures.
“The fundraising will allow us to accelerate our go-to-market plans, especially with AXA, to better support and empower women and couples everywhere.
“The acquisition of Altrui is especially exciting for us. It gives us a great opportunity to realise our vision of becoming the number one route for accessing and using fertility services.”
Idinvest Partners announces €350m digital fund
This comes as the brand recently acquired Altrui, the UK leader in egg donation services.
Femtech ventures received more than $1bn in funding from 2015-2018, and the trend is increasing both in the UK and worldwide, with an expected value of $50bn by 2025.
Stéphane Guinet, CEO of Kamet Ventures, added: “Kamet’s investments in ‘femtech’ recognise that this is a critical area of healthcare, with huge scope for innovation.
“Our work with Apricity is an important step in AXA’s broader strategy of making a positive difference to the lives of as many people as possible, all over the world.”